£111
−98%vs Nov 2024Active12312023Private limited companyAscot
ELIXA MEDISCIENCE LTD
Significant control: Prof Alan Michael Palmer (25–50%), Michael John Hudson (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Elixa Mediscience Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Elixa Mediscience Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
ELIXA MEDISCIENCE LTD is an active private limited company (company number 12312023) incorporated on 13 November 2019, registered in Ascot. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 November 2025, showing net assets of £111, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 98% on the prior period (£4,676). Across the last 3 periods on record the net-asset trend is volatile.
Peer position · net assets
By net assets it sits in the lower half of 50 comparable companies in Reading (median £11k, upper quartile £207k).
02
Ownership and control
- Prof Alan Michael Palmer
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr Michael John Hudson
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Professor Patrick Angel Camilleri
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr Richard Simon Todd
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 13 November 20196 yrs ago
- Next accounts due
- 30 August 2027in 309 days
- Confirmation statement due
- 27 November 2026in 33 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
2
No changevs Nov 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2025 | £111 | — | — | — | — | — | 2 |
| 30 November 2024 | £4,676 | — | — | — | — | — | 2 |
| 30 November 2023 | −£2,147 | — | — | — | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £111 at 30 November 2025
- Net assets down 25% or more on the prior period-97.6% vs prior period
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 13 November 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 309 days
- Confirmation statement duein 33 days
- Accounts period endNet assets £111 · micro accounts
- Accounts period endNet assets £4,676 · micro accounts
- Accounts period endNet liabilities £2,147 · micro accounts
- Incorporated
08
Similar companies in Reading
- HINZE TECH OPERATIONS LTDHook · inc. Nov 2019
- FISCHER CONSULTING LIMITEDMarlow · inc. Dec 2019
- NOVAI LTDReading · inc. Feb 2020
- KYNOS THERAPEUTICS LTDBourne End · inc. Mar 2020
- 272BIO LIMITEDReading · inc. Jun 2019
- INNOVATIVE INTERTRADE LTDBray On Thames · inc. May 2020
All companies incorporated on 13 November 2019 · in Nov 2019.
09
Reminders for ELIXA MEDISCIENCE LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.